ImmunoACT Becomes India’s First Profitable CAR‑T Startup in Year One
Mumbai‑based biotech startup ImmunoACT, a spin‑off incubated at IIT Bombay, has hit profitability in its first complete year of commercial operations, an unusual achievement in…
July 28
